Literature DB >> 30042872

Hepato-splenic axis: hepatic and splenic metabolic activities are linked.

Georgia Keramida1,2, Alexander Dunford3, Guven Kaya3, Constantinos D Anagnostopoulos4, Adrien Michael Peters2,3.   

Abstract

The concept of a hepato-splenic axis has recently been put forward. We aimed to investigate whether hepatic and splenic metabolic activities are linked, and if splenic metabolic activity is increased in non-alcoholic fatty liver disease (NAFLD). Blood clearance rates of phosphorylated 18F-fluorodeoxyglucose were measured in the spleen and liver from dynamic PET using Gjedde-Patlak-Rutland graphical analysis and abdominal aorta for input function in 59 patients undergoing routine PET/CT. Plot gradient (Ki), which represents blood clearance, was divided by intercept (V(0)), which represents tissue FDG distribution volume, and multiplied by blood glucose to give glucose uptake rate per unit tracer distribution volume (MRglu). In addition, liver-to-spleen raw count rate ratio was plotted against time, and gradient (b) divided by intercept (A) to obtain hepatic-to-splenic blood clearance ratio independent of aortic input function. Hepatic steatosis was inferred when hepatic CT density was ≤40 HU. There was no difference in splenic MRglu between 8 patients with inactive lympho-proliferative disease (LPD) as identified by negative PET/CT, 25 with non-haematological malignancy and 13 with normal PET/CT. It was significantly increased in 13 with active LPD, who were therefore excluded, along with 3 more with type-2 diabetes mellitus. Splenic MRglu was higher in patients with hepatic steatosis (4.0±1.6; n = 12) than without (2.6±1.7 μmol/min/100 ml; P = 0.02) and correlated inversely with hepatic CT density (r = -0.49; P<0.001). Hepatic and splenic Ki/V(0) correlated (r = 0.52; P<0.01) in 22 patients in whom the correlation coefficient between b/A and hepatic-to-splenic Ki/V(0) ratio was 0.99 and in whom, therefore, input function errors in graphical analysis could be discounted. In men, splenic longitudinal diameter correlated significantly with hepatic CT density (r = -0.35; P = 0.046), hepatic MRglu (r = 0.44; P = 0.005) and splenic MRglu (r = 0.35; P = 0.046). Splenic Ki/V(0) correlated positively with blood glucose, suggesting sensitivity to insulin. We conclude that hepatic and splenic metabolic activities are linked and that a speculative mechanism, which deserves further investigation, is shared insulin sensitivity. Splenic MRglu and spleen size are increased in NAFLD.

Entities:  

Keywords:  FDG; Glucose; PET; liver; metabolic rate; spleen

Year:  2018        PMID: 30042872      PMCID: PMC6056241     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  44 in total

1.  Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study.

Authors:  Go Akamatsu; Yasuhiko Ikari; Hiroyuki Nishida; Tomoyuki Nishio; Akihito Ohnishi; Akira Maebatake; Masayuki Sasaki; Michio Senda
Journal:  J Nucl Med Technol       Date:  2015-08-13

2.  Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.

Authors:  Lioe-Fee de Geus-Oei; Eric P Visser; Paul F M Krabbe; Bas A van Hoorn; Emile B Koenders; Antoon T Willemsen; Jan Pruim; Frans H M Corstens; Wim J G Oyen
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

Review 3.  Liver-spleen axis: intersection between immunity, infections and metabolism.

Authors:  Giovanni Tarantino; Antonella Scalera; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

4.  Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study.

Authors:  Patricia Iozzo; Fabian Geisler; Vesa Oikonen; Maija Mäki; Teemu Takala; Olof Solin; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Journal:  J Nucl Med       Date:  2003-05       Impact factor: 10.057

5.  Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver.

Authors:  Y Choi; R A Hawkins; S C Huang; R C Brunken; C K Hoh; C Messa; E U Nitzsche; M E Phelps; H R Schelbert
Journal:  J Nucl Med       Date:  1994-05       Impact factor: 10.057

6.  Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.

Authors:  Patricia Iozzo; Kirsti Hallsten; Vesa Oikonen; Kirsi A Virtanen; Jukka Kemppainen; Olof Solin; Ele Ferrannini; Juhani Knuuti; Pirjo Nuutila
Journal:  J Clin Endocrinol Metab       Date:  2003-05       Impact factor: 5.958

7.  Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography.

Authors:  Deepak R Subramanian; Lee Jenkins; Ross Edgar; Nabil Quraishi; Robert A Stockley; David G Parr
Journal:  Am J Respir Crit Care Med       Date:  2012-07-26       Impact factor: 21.405

8.  Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.

Authors:  Hamed Emami; Parmanand Singh; Megan MacNabb; Esad Vucic; Zachary Lavender; James H F Rudd; Zahi A Fayad; Joshua Lehrer-Graiwer; Magnus Korsgren; Amparo L Figueroa; Jill Fredrickson; Barry Rubin; Udo Hoffmann; Quynh A Truong; James K Min; Amos Baruch; Khurram Nasir; Matthias Nahrendorf; Ahmed Tawakol
Journal:  JACC Cardiovasc Imaging       Date:  2015-01-07

9.  Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females.

Authors:  Silvia Savastano; Carolina Di Somma; Genoveffa Pizza; Annalba De Rosa; Valeria Nedi; Annalisa Rossi; Francesco Orio; Gaetano Lombardi; Annamaria Colao; Giovanni Tarantino
Journal:  J Transl Med       Date:  2011-08-16       Impact factor: 5.531

10.  Hepatic glucose utilization in hepatic steatosis and obesity.

Authors:  Georgia Keramida; James Hunter; Adrien Michael Peters
Journal:  Biosci Rep       Date:  2016-11-03       Impact factor: 3.840

View more
  3 in total

1.  First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients.

Authors:  Hasan Sari; Clemens Mingels; Ian Alberts; Jicun Hu; Dorothee Buesser; Vijay Shah; Robin Schepers; Patrik Caluori; Vladimir Panin; Maurizio Conti; Ali Afshar-Oromieh; Kuangyu Shi; Lars Eriksson; Axel Rominger; Paul Cumming
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-04       Impact factor: 10.057

2.  Inflammatory response of gut, spleen, and liver in mice induced by orally administered Porphyromonas gingivalis.

Authors:  Yingman Liu; Wenkai Huang; Ke Dai; Ni Liu; Jiaqi Wang; Xiaoying Lu; Jiaojiao Ma; Manman Zhang; Mengqi Xu; Xu Long; Jie Liu; Yurong Kou
Journal:  J Oral Microbiol       Date:  2022-06-16       Impact factor: 5.833

Review 3.  Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy.

Authors:  Giovanni Tarantino; Vincenzo Citro; Domenico Capone
Journal:  J Clin Med       Date:  2019-12-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.